LH - LABORATORY CORP AMER HLDGS
This page shows which of the focused investors we track hold LH and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2015 it was held by 6 managers with an aggregate reported value of $1.06B, which is 0.14% of the combined portfolio.
As of Q3 2015, 6 tracked institutional managers held LH (LABORATORY CORP AMER HLDGS) with an aggregate reported value of $1.06B — 0.14% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades LH — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2015
- Ticker
- LH
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Viking Global Investors - Viking Global Investors | 2.10% | New | 5,053,349 | $548.14M |
| 2 | Christopher Davis - Davis Advisors | 0.92% | Reduce -51.7% | 2,036,449 | $220.89M |
| 3 | Ariel Investments - Ariel Investments | 2.20% | Add +8.4% | 1,627,421 | $176.53M |
| 4 | Wallace Weitz - Weitz Investment Management | 2.47% | Add +2.1% | 735,729 | $79.81M |
| 5 | Richard Pzena - Pzena Investment Management | 0.19% | Reduce -61.9% | 273,766 | $29.7M |
| 6 | First Pacific Advisors - First Pacific Advisors | 0.05% | - | 50,400 | $5.47M |
Loading holder history for LH…